The CNBC “Disruptor 50 List” is a list of 50 private companies whose innovations are revolutionizing their industries and the way we live. The majority of past CNBC Disruptor 50 are billion-dollar businesses. The 2021 CNBC “Disruptor 50 List” is the ninth such list.
Neteera is a 6-year-old Jerusalem startup with a revolutionary sensing technology capable of continuous, contactless, and clinical-grade monitoring of human vital signs such as heart and respiration rates, heart rate variability, respiration depth, and more – even through clothing. The Neteera proprietary solution monitors the mechanical activity of the heart (BCG) resulting in an accurate ECG equivalent data! It enables safe and seamless monitoring while reducing risk of hospital-associated infections caused by contamination from medical equipment and human contact.
Neteera has developed a highly accurate contactless and camera-free vital sign sensing system based on advanced proprietary algorithms and a digital sub-THz micro-radar system on a chip (SoC). This is a stressless and friction-less technology that can read biodata through clothing, with minimal patient involvement, without wires or the need for caregiver presence, and in the comfort of the patient’s home as well as hospitals and care facilities with no user interaction required.
The collected biodata is stored in the cloud to be used by the caregiver as the basis for better treatment decisions, which can be supported by artificial intelligence. Additional data provided over time will assist the caregiver in altering treatments and providing personalized care.
Neteera is pursuing a variety of use cases for the sensors: from detecting sleep apnea, managing chronic conditions like COPD, CHF and detecting sleep apnea in the home, preventing post-operative complications in the hospital, and screening for infectious disease symptoms in high density public places such as airports and shopping malls.
Neteera has been named a critical technology in the fight against Covid-19 by the Israeli Ministry of Defense. Neteera has completed a validation study at the Shaare Tzedek Medical Center showing the accuracy of the sensor is comparable to the gold standard wired monitoring system, according to founder and CEO Isaac Litman.
ABOUT NETEERA TECHNOLOGIES
Neteera is a Jerusalem-based hi-tech company focused on safeguarding and improving lives by developing a first-of-its-kind solution to monitor human physiological parameters in a contactless and continuous manner. Neteera’s revolutionary technology not only improves the quality of life but also safeguards patients and caregivers from hospital-associated infections (HAI’s) and disease. Neteera, launched in 2015, was formed out of research done at the Hebrew University of Jerusalem and has raised $19 million in funding. Its current valuation is $49 million. Mr. Litman, CEO, Neteera, is the former CEO of self-driving technology company Mobileye, which he led for six years. He raised an IPO in 2014 and the company was later sold to Intel for $15.3 billion.
Further information: www.neteera.com contact: pr AT neteera.com
Source: Psion Newswire
